Amp Capital Investors LTD Corcept Therapeutics Inc Transaction History

Amp Capital Investors LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $245,976 - $313,735	-20,047 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $292,485 - $511,198	20,047 New	20,047 $319,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $465,766 - $611,965	-29,535 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $363,280 - $570,025	29,535	29,535 $570,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.